Recruiting Obesity Studies in Louisville
A Research Study to Look Into the Long-term Effect on Weight Loss of CagriSema in People With Obesity
This study will look at how well CagriSema helps people with obesity lose weight compared to a "dummy medicine". CagriSema is a new medicine developed by Novo Nordisk. CagriSema cannot yet be prescrib...
GV101 in Healthy Obese Participants
The purpose of this trial is to evaluate the efficacy and safety of GV101 for weight loss over a range of doses in participants with obesity. The primary efficacy endpoint is the mean percent change i...
About Obesity Clinical Trials in Louisville
Obesity is a complex chronic disease involving an excessive amount of body fat that increases the risk of other diseases and health problems. It affects over 650 million adults worldwide. Treatment approaches include lifestyle modifications, medications (GLP-1 agonists), and bariatric surgery.
There are currently 2 obesity clinical trials recruiting participants in Louisville, KENTUCKY. These studies are seeking a combined 530 participants. Research is being sponsored by Novo Nordisk A/S, Graviton Bioscience Corporation. Clinical trial participation is free and participants receive study-related medical care at no cost.
Obesity Clinical Trials in Louisville — FAQ
Are there obesity clinical trials in Louisville?
Yes, there are 2 obesity clinical trials currently recruiting in Louisville, KENTUCKY. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Louisville?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Louisville research site will contact you about next steps.
Are clinical trials in Louisville free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Louisville studies also compensate for your time and travel.
What obesity treatments are being tested?
The 2 active trials in Louisville are testing new therapies including novel drugs, biologics, and treatment approaches for obesity.
Data updated March 2, 2026 from ClinicalTrials.gov